Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
Kahn Brothers Group Portfolio 13F
Kahn Brothers Group Holdings Activity
- Portfolio value:
- $627.75M≈ (-$9M≈)
- Previous value:
- $636.58M≈
- # of changes:
- 30
- New positions:
- 1
- Reported for:
- 31 Mar 2018 (Q1)
- Latest filing date:
- 01 May 2018
Kahn Brothers Group has disclosed a total of 30 changes to the portfolio in the (2018 Q1) SEC report(s): increased the number of shares of 7, bought 1 totally new, decreased the number of shares of 21 and completely sold out 1 position(s).
What stocks did Kahn Brothers Group buy in 2018 Q1?
During 2018 Q1 Kahn Brothers Group has bought 8 securities out of which top 5 purchases (by % change to portfolio) were (GSK) GlaxoSmithKline PLC ADR (added shares +8.03%), (AGO) ASSURED GUARANTY LTD (added shares +16.71%), (MBI) MBIA Inc (added shares +0.78%), (FLG) Flagstar Financial, Inc (added shares +15.96%) and (RFL) Rafael Holdings, Inc (new buy).
In the 2018 Q1 report(s) the following changes have been made to the top investments: (C) Citigroup Inc (reduced shares -3.40%), (BP) BP PLC-SPONS ADR (reduced shares -0.10%), (NYT) New York Times Company (reduced shares -22.36%), (BB) BlackBerry Ltd (reduced shares -1.88%) and (MRK) Merck & Company Inc (reduced shares -1.61%).
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.